What question did this study set out to answer?

This study aims to evaluate the impact of denopamine on the life span of cardiomyopathic hamsters during heart failure.

Prolongation of the Life Span of Cardiomyopath : Hamster by the Adrenergic β1-Selective Partial Agonist Denopamine

View Full Paper

Ask AI

Bookmark

Why the study?

Does denopamine improve survival in cardiomyopathic hamsters in the heart failure period?

Population

Cardiomyopathic hamsters (BIO 14.6 strain) in the heart failure period

Comparison

Denopamine starting from 36 weeks of age vs Non-treated hamsters

Design

Preclinical

Follow-up

Until 65 weeks of age

Authors

Denopamine may extend survival in hamster cardiomyopathy; leaves open human translation and requires prospective trials.

This study aims to evaluate the impact of denopamine on the life span of cardiomyopathic hamsters during heart failure.
Cardiomopathic hamsters were treated with denopamine (400 ppm) starting at 36 weeks of age.
Survival rates were compared between treated and non-treated groups up to 65 weeks.
Plasma levels of noradrenaline and dopamine were measured post-treatment.
Non-treated hamsters had a survival rate of 23.8% at 65 weeks; treated hamsters had a survival rate of about 40%.
Treating with denopamine delayed mortality until 52 weeks, excluding accidental deaths (P < 0.05).
Denopamine significantly lowered plasma noradrenaline and dopamine levels (P < 0.05) without affecting cardiac contractility.

Does denopamine improve survival in cardiomyopathic hamsters in the heart failure period?

Population

Cardiomyopathic hamsters (BIO 14.6 strain) in the heart failure period

Intervention

Denopamine (400 ppm in diet) starting from 36 weeks of age

Comparator

Non-treated hamsters

Outcome

Survival rate at 65 weeks of agehard clinical

Denopamine significantly decreases mortality in a hamster model of heart failure, potentially mediated by lowering plasma catecholamine levels.

Kurosawa et al. (1996) studied this question.

View Full Paper

Ask AI

Bookmark